These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27357932)

  • 1. A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Falk RT; Staff AC; Bradwin G; Karumanchi SA; Troisi R
    Cancer Causes Control; 2016 Aug; 27(8):1009-17. PubMed ID: 27357932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
    Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
    Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.
    Januzzi JL; Liu Y; Sattar N; Yavin Y; Pollock CA; Butler J; Jardine M; Heerspink HJL; Masson S; Breyer M; Hansen MK
    Am Heart J; 2024 May; 271():38-47. PubMed ID: 38401646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal placental growth factor and soluble fms-like tyrosine kinase-1 reference ranges in post-term pregnancies: A prospective observational study.
    Mitlid-Mork B; Bowe S; Gran JM; Bolstad N; Berg JP; Redman CW; Staff AC; Sugulle M
    PLoS One; 2020; 15(10):e0240473. PubMed ID: 33079955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of laser surgery on angiogenic and anti-angiogenic factors in twin-twin transfusion syndrome: a prospective study
    Chon AH; Chavira ER; Wilson ML; Ingles SA; Llanes A; Chmait RH
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1085-1091. PubMed ID: 28320252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
    Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
    Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
    Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
    Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.
    Yang WC; Chen CY; Chou HC; Hsieh WS; Tsao PN
    Pediatr Neonatol; 2015 Dec; 56(6):382-5. PubMed ID: 25997993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
    Shinohara S; Uchida Y; Kasai M; Sunami R
    Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.
    Bowe S; Mitlid-Mork B; Georgieva A; Gran JM; Redman CWG; Staff AC; Sugulle M
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1893-1901. PubMed ID: 34212381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiogenic factors and HIV among pregnant women in Zambia: a nested case-control study.
    Smithmyer ME; Mabula-Bwalya CM; Mwape H; Chipili G; Spelke BM; Kasaro MP; De Paris K; Vwalika B; Sebastião YV; Stringer JSA; Price JT
    BMC Pregnancy Childbirth; 2021 Jul; 21(1):534. PubMed ID: 34320947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble fms-like tyrosine kinase 1 (sFlt-1): A novel biochemical marker for acute fatty liver of pregnancy.
    Trottmann F; Raio L; Amylidi-Mohr S; Mosimann B; Jarquin Campos A; Messerli FH; Risch L; Baumann MU
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1876-1884. PubMed ID: 34157141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
    Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
    PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study.
    Peguero A; Fernandez-Blanco L; Mazarico E; Benitez L; Gonzalez A; Youssef L; Crispi F; Hernandez S; Figueras F
    BJOG; 2021 Jan; 128(2):158-165. PubMed ID: 32593222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.